Furosemide

Product NDC: 71610-308
Requested package NDC: 71610-308-30
11-digit product format: 716100308
Labeler code: 71610
Product ID: 71610-308_f0960a17-009b-4da4-b2cc-7851e22a2165
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Furosemide
Dosage form: TABLET
Route: ORAL
Labeler: Aphena Pharma Solutions - Tennessee, LLC
Application: NDA018823
Marketing category: NDA
Marketing start: 1983-11-10
Marketing end: 0000-00-00
Substance: FUROSEMIDE
Active strength: 40 mg/1
Pharmacologic classes: Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	71610-308	71610-308-30	I	Inactivated by FDA		2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N018823-001	FUROSEMIDE	FUROSEMIDE	20MG	TABLET / ORAL	AB		1983-11-10
N018823-002	FUROSEMIDE	FUROSEMIDE	40MG	TABLET / ORAL	AB		1983-11-10

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N018823-001	AB
N018823-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018823-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	1983-11-10	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N018823-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	1983-11-10	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N018823-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018823-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018823-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018823-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018823-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018823-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018823-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018823-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018823-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018823-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018823-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018823-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018823-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018823-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018823-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018823-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018823-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018823-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N018823-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N018823-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018823-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018823-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018823-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018823-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018823-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018823-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018823-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N018823-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018823-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018823-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018823-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N018823-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018823-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N018823-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018823-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018823-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018823-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N018823-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018823-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N018823-002	AB	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d80d3aff-3a63-4d7b-a2be-fd9388b04330	Product name	9	20250806
9061e89f-9c86-4196-b34b-886fc1673cc4	Product name	1	20140821

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
71610-308-30	FUROSEMIDE Tablets USP
71610-308-45	FUROSEMIDE Tablets USP
71610-308-53	FUROSEMIDE Tablets USP
71610-308-60	FUROSEMIDE Tablets USP
71610-308-80	FUROSEMIDE Tablets USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
71610-308-30	Furosemide	30 in 1 BOTTLE	TABLET	30	1
71610-308-45	Furosemide	45 in 1 BOTTLE	TABLET	45	1
71610-308-53	Furosemide	60 in 1 BOTTLE	TABLET	60	1
71610-308-60	Furosemide	90 in 1 BOTTLE	TABLET	90	1
71610-308-80	Furosemide	180 in 1 BOTTLE	TABLET	180	1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
71610-308-30	EA - Each	71610-308	906b4b45-5f32-4b47-9c74-6c57f2e92ef5	1	2019-09-05
71610-308-45	EA - Each	71610-308	5e15d534-df5e-4d7f-adbb-14aea35477c5	1	2019-10-07
71610-308-53	EA - Each	71610-308	d026aac3-1b42-4404-b4ae-d66c3a139386	1	2019-09-05
71610-308-60	EA - Each	71610-308	b02bb1ac-cc39-4233-8a77-dc6db5fad68a	1	2019-09-05
71610-308-80	EA - Each	71610-308	28246d4c-092d-4036-bcf1-622a1293d300	1	2019-09-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71610-308	FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1	Legacy NDC, 5 package rows	20190817_a0dd45a3-4ae8-4301-8d6c-a20eac80cb2c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Furosemide	FUROSEMIDE	Northwind Health Company, LLC	f3173c0d-2b62-7c7b-e053-2995a90ada05	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018823 application number: NDA018823
Furosemide	FUROSEMIDE	Hikma Pharmaceuticals USA Inc.	9e493331-dddd-496e-abf8-61747fb67aba	2025-11-03	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018823 application number: NDA018823
Furosemide	FUROSEMIDE	A-S Medication Solutions	a2e46e16-4adf-4599-b69d-a6f6f891ba75	2023-10-31	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018823 application number: NDA018823
Furosemide	FUROSEMIDE	Aphena Pharma Solutions - Tennessee, LLC	6fbf7f3d-7566-44d5-9507-c4460238fc91	2018-02-09	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018823 application number: NDA018823

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7LXU5N7ZO5	FUROSEMIDE	54-31-9	FUROSEMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310429	furosemide 20 MG Oral Tablet	PSN	a0dd45a3-4ae8-4301-8d6c-a20eac80cb2c	1
313988	furosemide 40 MG Oral Tablet	PSN	a0dd45a3-4ae8-4301-8d6c-a20eac80cb2c	1
197732	furosemide 80 MG Oral Tablet	PSN	a0dd45a3-4ae8-4301-8d6c-a20eac80cb2c	1
310429	furosemide 20 MG Oral Tablet	SCD	a0dd45a3-4ae8-4301-8d6c-a20eac80cb2c	1
313988	furosemide 40 MG Oral Tablet	SCD	a0dd45a3-4ae8-4301-8d6c-a20eac80cb2c	1
197732	furosemide 80 MG Oral Tablet	SCD	a0dd45a3-4ae8-4301-8d6c-a20eac80cb2c	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
71610-308-30	71610030830	30 TABLET in 1 BOTTLE (71610-308-30)	30 tablet	2019-07-16	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
FUROSEMIDE Tablets USP	Aphena Pharma Solutions - Tennessee, LLC	2019-07-17	HUMAN PRESCRIPTION DRUG LABEL	1